Urine trypsinogen-2 as marker of acute pancreatitis

Clinical Chemistry

Volumn 42, Issue 5, 1996, Pages 685-690

  Hedström, Johan ^a,b   Sainio, Vesa ^a   Kemppainen, Esko ^a   Puolakkainen, Pauli ^a   Haapiainen, Reijo ^a   Kivilaakso, Eero ^a   Schauman, Knut Olof ^b   Stenman, Ulf Håkan ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

amylase; proenzymes; proteases; time resolved immunofluorometric assay; trypsinogen activation peptides; urine marker

Indexed keywords

AMYLASE; TRYPSINOGEN;

ACUTE ABDOMEN; ACUTE PANCREATITIS; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; EARLY DIAGNOSIS; ENZYME BLOOD LEVEL; ENZYMURIA; FEMALE; FLUOROIMMUNOASSAY; HUMAN; MAJOR CLINICAL STUDY; MALE; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; URINALYSIS;

EID: 0029940768     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/42.5.685     Document Type: Article

References (27)

1. Ohlsson K, Eddeland A. Release of proteolytic enzymes in bile-induced pancreatitis in dogs. Gastroenterology 1975;69:668-75.
2. Lasson A, Ohlsson K. Protease inhibitors in acute human pancreatitis. Correlation between biochemical changes and clinical course. Scand J Gastroenterol 1984;19:779-86.
3. Ohlsson K. Acute pancreatitis. Biochemical, pathophysiological and therapeutical aspects. Acta Gastroenterol Belg 1988;51:3-12.
4. Itkonen O, Koivunen E, Hurme M, Alfthan H, Schröder T, Stenman U-H. Time-resolved immunofluorometric assays for trypsinogen-1 and 2 in serum reveal preferential elevation of trypsinogen-2 in pancreatitis. J Lab Clin Med 1990;115:712-8.
5. Figarella C, Amouric M, Carrere J, Miszczuk Jamska B, Guy Crotte O. Pancreatic proteins in normal state and pancreatic diseases in pancreatic juice and blood. Ric Clin Lab 1984;14:349-59.
6. Durie PR, Gaskin KJ, Geokas MC, O'Rourke MO, Largman C. Plasma immunoreactive anionic pancreatic trypsin in cystic fibrosis. J Pediatr Gastroenterol Nutr 1982;1:337-43.
7. Kimland M, Russick C, Marks WH, Borgström A. Immunoreactive anionic and cationic trypsin in human serum. Clin Chim Acta 1989;184:31-46.
8. 1-antitrypsin in serum. Clin Chem 1994;40:1761-5.
9. Moossa AR. Diagnostic tests and procedures in acute pancreatitis. N Engl J Med 1984;311:639-43.
10. Salt WB, Schenker S. Amylase - its clinical significance: a review of the literature. Medicine 1976;55:269-89.
11. Clavien PA, Burgan S, Moossa AR. Serum enzymes and other laboratory tests in acute pancreatitis. Br J Surg 1989;76:1234-43.
12. Saxon EI, Hinkley WC, Vogel WC, Zieve L. Comparative value of serum and urinary amylase in the diagnosis of acute pancreatitis. Arch Intern Med 1957;99:607-21.
13. Hurley PR, Cook A, Jehanli A, Austen BM, Hermon Taylor J. Development of radioimmunoassays for free tetra-L-aspartyl-L-lysine trypsinogen activation peptides (TAP). J Immunol Methods 1988;111:195-203.
14. Gudgeon AM, Heath DI, Hurley P, Jehanli A, Patel G, Wilson C, et al. Trypsinogen activation peptides assay in the early prediction of severity of acute pancreatitis. Lancet 1990;335:4-8.
15. Kivisaari L, Somer K, Standertskjöld-Nordenstam CG, Schröder T, Kivilaakso E, Lempinen M. A new method for the diagnosis of acute hemorrhagic-necrotizing pancreatitis using contrast-enhanced CT. Gastrointest Radiol 1984;9:27-30.
16. SCE. Nordic alpha-amylase study II. Assessment of proposed calibration procedure. A report by the Scandinavian Committee on Enzymes (SCE). Scand J Clin Lab Invest 1986;46:465-9.
17. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine [Review]. Clin Chem 1993;39:561-77.
18. Feldmann U, Schneider B, Klinkers H. A multivariate approach for the biometric comparison of analytical methods in clinical chemistry. J Clin Chem Clin Biochem 1981;19:121-37.
19. Albo R, Silen W, Goldman L. A critical analysis of acute pancreatitis. Arch Surg 1963;86:1032-5.
20. Mogensen CE, Solling K. Studies on renal tubular protein reabsorption: partial and near complete inhibition by certain amino acids. Scand J Clin Lab Invest 1977;37:477-86.
21. Johnson SG, Ellis CJ, Levitt MD. Mechanism of increased renal clearance of amylase/creatinine in acute pancreatitis. N Engl J Med 1976;295:1214-7.
22. Elias E, Redshaw M, Wood T. Diagnostic importance of changes in circulating concentrations of immunoreactive trypsin. Lancet 1977;ii:66-8.
23. Brodrick JW, Geokas MC, Largman C, Fassett M, Johnson JH. Molecular forms of immunoreactive pancreatic cationic trypsin in pancreatitis patient sera. Am J Physiol 1979;237:474-80.
24. Largman C, Brodrick JW, Geokas MC, Johnson JH. Demonstration of human pancreatic anionic trypsinogen in normal serum by radioimmunoassay. Biochim Biophys Acta 1978;543:450-4.
25. Corfield AP, Cooper MJC, Williamson RCN. Acute pancreatitis: a lethal disease of increasing incidence. Gut 1985;26:724-9.
26. Thomson HJ, Brydon WG, Obekpa PO, Smith AN. Screening for acute pancreatitis. J R Coll Surg Edinb 1987;32:348-51.
27. Gunn IR, Faye S, Clayton MGG. Prospective evaluation of urinary amylase test strip [Letter]. Lancet 1986;ii:1161.